Single injection of novel hydrogel could replace weekly diab

Materials engineers at Stanford University have developed a novel hydrogel drug delivery system that transforms daily or weekly injections of diabetes and weight control drugs like Ozempic, Mounjaro, Trulicity, Victoza, and others to just once every four months.

Related Keywords

United States , America , Carolyn Jons , Enmian Chang , Caitlin Maikawa , Leslee Nguyen , Stanford Bio , Ian Hall , Katie Lu , Jerry Yan , Alexander Prossnitz , Eric Appel , Sam Baker , Catherine Kasse , Stanford Diabetes Research Center , Stanford University School Of Engineering , Stanford Woods Institute For The Environment , Cardiovascular Institute , Stanford Cancer Institute , Wu Tsai Neurosciences Institute , Stanford University , Maternal Child Health Research Institute , National Institute Of Diabetes , Novo Nordisk , Wu Tsai Human Performance Alliance , University School , Cell Reports Medicine , Stanford Woods Institute , Stanford Bio X , Child Health Research Institute , National Institute , Kidney Diseases , Stanford Diabetes Research , Diabetes , Drug Delivery , Fell , Diet , Drugs , Glp 1 , Glucagon , Ormone , Hydrogel , Medicine , Olecule , Anoparticles , Obesity , Research , Skin , Students , Technology , Sai , Type 2 Diabetes ,